Divisions of Critical Care Medicine and Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX.
Division of Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX.
Pediatr Crit Care Med. 2019 Nov;20(11):1040-1047. doi: 10.1097/PCC.0000000000002038.
Hospitalized children with underlying heart disease are at high risk for cardiac arrest, particularly when they undergo invasive catheterization procedures for diagnostic and therapeutic interventions. Outcomes for children experiencing cardiac arrest in the cardiac catheterization laboratory remain under-reported with few studies reporting survival beyond the catheterization laboratory. We aim to describe survival outcomes after cardiac arrest in the cardiac catheterization laboratory while identifying risk factors associated with hospital mortality after these events.
Retrospective observational study of data from a multicenter cardiac arrest registry from November 2005 to November 2016. Cardiac arrest in the cardiac catheterization laboratory was defined as the need for chest compressions greater than or equal to 1 minute in the cardiac catheterization laboratory. Primary outcome was survival to discharge. Variables analyzed using generalized estimating equations for association with survival included age, illness category (surgical cardiac, medical cardiac), preexisting conditions, pharmacologic interventions, and event duration.
American Heart Association's Get With the Guidelines-Resuscitation registry of in-hospital cardiac arrest.
Consecutive patients less than 18 years old experiencing an index (i.e., first) cardiac arrest event reported to the Get With the Guidelines-Resuscitation.
None.
A total of 203 patients met definition of index cardiac arrest in the cardiac catheterization laboratory composed primarily of surgical and medical cardiac patients (54% and 41%, respectively). Children less than 1 year old comprised the majority of patients, 58% (117/203). Overall survival to hospital discharge was 69% (141/203). No differences in survival were observed between surgical and medical cardiac patients (p = 0.15). The majority of deaths (69%, 43/62) occurred in patients less than 1 year old. Bradycardia (with pulse) followed by pulseless electrical activity/asystole were the most common first documented rhythms observed (50% and 27%, respectively). Preexisting metabolic/electrolyte abnormalities (p = 0.02), need for vasoactive infusions (p = 0.03) prior to arrest, and use of calcium products (p = 0.005) were found to be significantly associated with lower rates of survival to discharge on multivariable regression.
The majority of children experiencing cardiac arrest in the cardiac catheterization laboratory in this large multicenter registry analysis survived to hospital discharge, with no observable difference in outcomes between surgical and medical cardiac patients. Future investigations that focus on stratifying medical complexity in addition to procedural characteristics at the time of catheterization are needed to better identify risks for mortality after cardiac arrest in the cardiac catheterization laboratory.
患有基础心脏病的住院儿童发生心搏骤停的风险很高,尤其是在接受诊断和治疗介入的有创导管插入术时。心脏导管插入术实验室中发生心搏骤停的儿童的结局报告仍然不足,很少有研究报告这些事件后在导管插入术实验室之外的存活率。我们旨在描述心脏导管插入术实验室中心搏骤停后的存活结局,并确定与这些事件后医院死亡率相关的危险因素。
对 2005 年 11 月至 2016 年 11 月期间多中心心脏骤停登记处的数据进行回顾性观察性研究。心脏导管插入术实验室中心搏骤停定义为需要在心脏导管插入术实验室中进行大于或等于 1 分钟的胸外按压。主要结局是出院时的存活率。使用广义估计方程分析与存活相关的变量包括年龄、疾病类别(心脏手术、心脏医学)、既往疾病、药物干预和事件持续时间。
美国心脏协会的 Get With the Guidelines-Resuscitation 院内心脏骤停注册处。
符合 Get With the Guidelines-Resuscitation 报告的索引(即第一次)心脏骤停事件的年龄小于 18 岁的连续患者。
无。
共有 203 名患者符合心脏导管插入术实验室中心搏骤停的定义,主要由心脏手术和心脏医学患者组成(分别为 54%和 41%)。年龄小于 1 岁的患儿占多数,为 58%(117/203)。总体出院存活率为 69%(141/203)。心脏手术和心脏医学患者之间的存活率无差异(p = 0.15)。大多数死亡(69%,43/62)发生在年龄小于 1 岁的患者中。最常见的首次记录节律是心动过缓(有脉搏)继之心电活动/停搏(分别为 50%和 27%)。在心脏骤停之前发现的预先存在的代谢/电解质异常(p = 0.02)、需要血管活性输注(p = 0.03)以及钙制品的使用(p = 0.005)在多变量回归中发现与出院存活率显著相关。
在这项大型多中心登记分析中,大多数在心脏导管插入术实验室中心搏骤停的儿童存活出院,手术和心脏医学患者之间的结局无明显差异。需要进一步的研究,重点关注除导管插入术时的程序特征外,还分层医疗复杂性,以更好地确定心脏导管插入术实验室中心搏骤停后死亡率的风险。